Advaxis, Inc. - Product Pipeline Review - 2016

Published: Apr, 2016 | Pages: 82 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Advaxis, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, ‘Advaxis, Inc. - Product Pipeline Review - 2016', provides an overview of the Advaxis, Inc.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Advaxis, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Advaxis, Inc.
- The report provides overview of Advaxis, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Advaxis, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Advaxis, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy

- Evaluate Advaxis, Inc.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Advaxis, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Advaxis, Inc.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

 Table of Content
Table of Contents 2

List of Tables 5
List of Figures 5
Advaxis, Inc. Snapshot 6
Advaxis, Inc. Overview 6
Key Information 6
Key Facts 6
Advaxis, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Advaxis, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Advaxis, Inc. - Pipeline Products Glance 12
Advaxis, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Advaxis, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Advaxis, Inc. - Drug Profiles 15
axalimogene filolisbac 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ADXS-HER2 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ADXS-PSA 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Adxs-LmddA159 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
ADXS-NEO 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
ADXS-TNBC 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Lm-LLO-CA9 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Lm-LLO-CD105A 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Lm-LLO-Flk1 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Lm-LLO-HMWMAAC 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Lm-LLO-ISG15 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Lovaxin S 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Vaccine to Target CEA for Ovarian Cancer 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Vaccine to Target FAP for Breast and Colorectal Cancer 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Vaccine to Target HER2 and CA9 for Breast Cancer 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Vaccine to Target Her2 and HMWMAA for Breast Cancer 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Vaccine to Target IL-13R Alpha2 for Solid Tumor 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Vaccine to Target PSA and HMWMAA for Prostate Cancer 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Vaccine to Target PSCA for Prostate Cancer 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Vaccine to Target WT1 for Oncology 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Advaxis, Inc. - Pipeline Analysis 55
Advaxis, Inc. - Pipeline Products by Target 55
Advaxis, Inc. - Pipeline Products by Route of Administration 57
Advaxis, Inc. - Pipeline Products by Molecule Type 58
Advaxis, Inc. - Recent Pipeline Updates 59
Advaxis, Inc. - Dormant Projects 75
Advaxis, Inc. - Company Statement 76
Advaxis, Inc. - Company Statement 76
Advaxis, Inc. - Locations And Subsidiaries 80
Head Office 80
Appendix 81
Methodology 81
Coverage 81
Secondary Research 81
Primary Research 81
Expert Panel Validation 81
Contact Us 81
Disclaimer 82

List of Tables

Advaxis, Inc., Key Information 6
Advaxis, Inc., Key Facts 6
Advaxis, Inc. - Pipeline by Indication, 2016 8
Advaxis, Inc. - Pipeline by Stage of Development, 2016 10
Advaxis, Inc. - Monotherapy Products in Pipeline, 2016 11
Advaxis, Inc. - Phase II, 2016 12
Advaxis, Inc. - Phase I, 2016 13
Advaxis, Inc. - Preclinical, 2016 14
Advaxis, Inc. - Pipeline by Target, 2016 55
Advaxis, Inc. - Pipeline by Route of Administration, 2016 57
Advaxis, Inc. - Pipeline by Molecule Type, 2016 58
Advaxis, Inc. - Recent Pipeline Updates, 2016 59
Advaxis, Inc. - Dormant Developmental Projects,2016 75